Abstract:Overview: Gustavo E. Sevlever Approximately 40% of global dementia cases in high-income countries are attributed to potentially modifiable risk factors, whereas in Latin America, this figure rises to 56%. This difference underscores the importance of initiating preventive trials in the region. LatAm- FINGERS is the first non-pharmacological multicenter randomized clinical trial in Latin America, involving 12 countries: Argentina, Brazil, Bolivia, Chile, Colombia, Costa Rica, Ecuador, Mexico, Puerto Rico, the Dominican Republic, and Uruguay. The trial aims to prevent cognitive impairment through a multidomain lifestyle intervention. It evaluates the feasibility and efficacy of these interventions in enhancing cognitive function among 1,200 participants over two years. The lifestyle intervention, modeled after the Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER), encompasses nutrition, physical exercise, cardiovascular risk factor management, cognitive training, and socialization. Harmonization processes have ensured consistency with FINGER and the U.S. Study to Protect Brain Health through Lifestyle Intervention to Reduce Risk (U.S. POINTER) across Latin America. Since recruitment commenced in December 2021, 1,867 participants have been screened, with 1,186 enrolled. The cohort is predominantly female (73.8%), with an average age of 67.41 years, representing diverse ethnic backgrounds. LatAm-FINGERS has established the largest dataset on dementia risk in the region, evolving into a comprehensive database for cognitive, imaging, biomarker, and genetic research. It aims to promote collaborative efforts in dementia prevention across Latin America. In this session, we will provide an overview of the trial's Objectives and outcomes, the basis for the multidomain interventions, and describe the recruitment and adherence strategies implemented. We will conclude with results regarding the association of cardiovascular risk factors with social determinants of health. 1: Lucía Crivelli LatAm-FINGERS: Establishing Eligibility and Outcomes for Effective Research Across Latin America Objectives: LatAm-FINGERS is the first non-pharmacological, multicenter randomized clinical trial in Latin America, involving 12 countries and aiming to prevent cognitive impairment. The trial's primary Objectives is to assess the feasibility and efficacy of a multidomain lifestyle intervention in improving cognitive function among 1,200 participants over two years. Additionally, this study aims to evaluate the validity properties of cognitive outcomes within the LatAm-FINGERS cohort. Methods: To ensure consistency, the study employed harmonization processes with the original FINGER trial and the U.S. POINTER trial as part of the Worldwide FINGERS initiative. Eligibility criteria were standardized using normative z-scores. The Latin American Neuropsychological Battery (LatAm-NTB) was developed, including tests such as the Free and Cued Selective Reminding Test, Logical Memory, Digit Span, Stroop Test, Concept Shifting Test, Trail Making Test, Symbol Digit Modalities Test, and semantic and phonological fluency. A multivariate regression model was used to evaluate the validity of the LatAm-NTB. Results: Since recruitment began in December 2021, 1,186 participants have been enrolled. The mean age is 67.41 years (SD = 4.65), with an average educational level of 12.9 years (SD = 3.7) and an average Mini-Mental State Examination (MMSE) score of 27.2 (SD = 2.17). Women comprise 73.8% of the cohort. A multivariate regression model, which included sociodemographic variables, non-modifiable risk factors, and cardiovascular risk, was constructed to explain cognitive performance. This model demonstrated better fit parameters (BIC: 734.649, AIC: 793.661) compared to the reduced model (BIC: 1041.591, AIC: 1051.426). Higher education (β = 0.04, SE = 0.003, p < .001), younger age (β = –0.01, SE = 0.002, p < .001), and a lower Framingham Risk Score (β = –0.01, SE = 0.003, p < .001) were associated with better cognitive performance. Being male was not significantly associated with cognitive outcomes (β = –0.01, SE = 0.02, p = 0.57). Conclusions: Eligibility criteria were adequate to select the targeted population. The results suggest that the LatAm-NTB has promising validity indicators for assessing cognition in a follow- up clinical trial in Latin America. 2: Ana Charamelo Design and Harmonization of Interventions, barriers, and challenges Background: The Objectives of this analysis is to show how an intervention in Latin American lifestyles to prevent cognitive deterioration was initiated, its design, and what harmonization strategies were used, taking into account the multiculturalism of this population, constituted by 12 countries throughout the continent. It is the first randomized, multicenter, non- pharmacolog -Abstract Truncated-

Recruitment and Baseline Characteristics of Participants in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)—A Randomized Controlled Lifestyle Trial

Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: The FINGER trial

Psychosocial determinants for adherence to a healthy lifestyle and intervention participation in the FINGER trial: an exploratory analysis of a randomised clinical trial

Brain volumes and cortical thickness on MRI in the Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability (FINGER)

A multimodal precision-prevention approach combining lifestyle intervention with metformin repurposing to prevent cognitive impairment and disability: the MET-FINGER randomised controlled trial protocol

Dementia prevention: The potential long-term cost-effectiveness of the FINGER prevention program

MULTIDOMAIN INTERVENTIONS TO PREVENT COGNITIVE IMPAIRMENT, ALZHEIMER’S DISEASE, AND DEMENTIA: FROM FINGER TO WORLD-WIDE FINGERS

Subjective Memory Complaints and the Effect of a Multidomain Lifestyle Intervention on Cognition: The FINGER Trial

World-Wide FINGERS Network: A global approach to risk reduction and prevention of dementia

A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults—study design and baseline characteristics of the FINGER-NL randomized controlled trial

GOIZ ZAINDU study: a FINGER-like multidomain lifestyle intervention feasibility randomized trial to prevent dementia in Southern Europe

S4: The LatAm-FINGERS Initiative: The First Non-Pharmacological Randomized Controlled Trial to Prevent Cognitive Decline Across Latin America

Brain Training, Exercise, and Healthy Eating Slow Cognitive Decline in Elderly People at Risk, Study Finds.

The Australian National University Alzheimer's Disease Risk Index (ANU‐ADRI) score as a predictor for cognitive decline and potential surrogate outcome in the FINGER lifestyle randomized controlled trial

Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease

Finger Exercise Alleviates Mild Cognitive Impairment of Older Persons: A Community-Based Randomized Trial.

Effect of the Apolipoprotein E Genotype on Cognitive Change During a Multidomain Lifestyle Intervention: A Subgroup Analysis of a Randomized Clinical Trial

Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial

The SINgapore GERiatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER): Study Design and Protocol

Development of a Cognitive Training Support Programme for prevention of dementia and cognitive decline in at-risk older adults

Multidomain Intervention for Reversal of Cognitive Frailty, Towards a Personalized Approach (AGELESS Trial): Study Design